News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News ACC 2017 Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI L.A. McKeown March 09, 2017
News Conference News ACC 2017 Sodium Restriction Message Not Getting Through to Hypertensive Patients Todd Neale March 08, 2017
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Conference News ACC 2015 MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin Todd Neale March 17, 2015
News Conference News ACC 2014 ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients Caitlin E. Cox April 02, 2014
News Conference News ACC 2013 STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital Yael L. Maxwell March 09, 2013
News Conference News ACC 2013 PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device L.A. McKeown March 09, 2013
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012